FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3931211000001105: Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26558901000001112 Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65904701000001112 Orelox 40mg/5ml oral suspension paediatric (Sanofi) 50 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Is a Cefpodoxime 40mg/5ml oral suspension 50 ml true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Is pack of Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has active ingredient Cefpodoxime proxetil false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has active ingredient Cefpodoxime false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has excipient Aspartame false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has excipient Lactose false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has AMP Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cefpodoxime true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has specific active ingredient Cefpodoxime proxetil true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has basis of strength substance Cefpodoxime true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start